[Case contribution to local trenimon intolerance].
D000477:Alkylating Agents / Q000009:adverse effects*; D001389:Azirines / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008875:Middle Aged; D014228:Triaziquone / Q000009:adverse effects; D014456:Ulcer / Q000209:etiology*
D000477:Alkylating Agents; D001389:Azirines; D014228:Triaziquone
Kasuistischer Beitrag zur lokalen Trenimon-Unverträglichkeit.